乳腺癌筛查中放射状硬化性病变的恶性升级率
本研究为回顾性研究,检索两家三级乳腺中心2012年3月1日至2017年12月31日间经活检证实的放射状瘢痕和放射状硬化性病变(RS),所有乳腺X线摄影均采用数字乳腺断层合成(DBT)。共在142名女性中识别出146个活检证实的RS,其中无 atypia 或恶性变的RS中恶性升级率为0.9%(1/117,95%CI:0.02,4.7)。结论认为无 atypia 的RS升级率低。
要点
- 无 atypia 或恶性变的 RS 恶性升级率为 0.9%(1/117,95%CI:0.02,4.7)。
- 80.1%(117/146)的 RS 无相关 atypia 或恶性变,19.9%(29/146)在初始活检时有相关 atypia。
- 无 atypia 的 RS 中 66.7%(78/117)行手术切除,25.6%(30/117)随访(中位3年)影像学良性。
核心结论
- 无 atypia 的放射状硬化性病变恶性升级率低,为 0.9%(1/117,95%CI:0.02,4.7)。
研究设计与样本
- 回顾性研究,检索两家三级乳腺中心2012年3月1日至2017年12月31日经活检证实的RS,期间所有乳腺X线摄影均采用数字乳腺断层合成(DBT);共146个活检证实的RS来自142名女性(中位年龄58岁,范围26-87岁)。
诊断标准与关键数值
- 无 atypia 或恶性变的 RS 恶性升级率为 0.9%(1/117,95%CI:0.02,4.7);初始活检时 80.1%(117/146)的 RS 无相关 atypia 或恶性变,19.9%(29/146)有相关 atypia。
临床应用与阅片要点
- 本研究中心在DBT发现病变后使用MRI或US等辅助模态以更好地表征病变;无 atypia 的 RS 中 66.7%(78/117)行手术切除,25.6%(30/117)随访(中位3年,范围1-7年)影像学良性,7.7%(9/117)失访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine the upgrade rate for biopsy-proven radial scars and radial sclerosing lesions (RS). Materials and Methods In this retrospective study, radiology and pathology databases from two tertiary breast centers were searched to identify patients with biopsy-confirmed RS between March 1, 2012, and December 31, 2017, during which all mammography was performed with digital breast tomosynthesis (DBT). Adjunct modalities such as MRI or US are performed at our centers to better characterize lesions identified at DBT. Patient demographics, imaging, needle and excisional biopsies, and follow-up data were collected at the patient level. Clopper-Pearson interval estimate for upgrade was calculated for 95% confidence using PropCIs package with R version 4.1.0 (R Foundation for Statistical Computing) (1). Results During the study period, a total of 155 885 DBT examinations were performed. From these examinations, 146 biopsy-proven RS were identified in 142 women (median age, 58 years; age range, 26-87 years). A total of 80.1% (117 of 146) of all RS did not have associated atypia or malignancy, and 19.9% (29 of 146) had associated atypia at initial biopsy. A total of 66.7% (78 of 117) of RS without atypia or malignancy were surgically excised, 25.6% (30 of 117) were followed (median, 3 years; range, 1-7 years) with benign findings on imaging, and 7.7% (nine of 117) were lost to follow-up. The rate of malignancy upgrade was 0.9% (one of 117 [95% CI: 0.02, 4.7]); one RS without concurrent atypia or malignancy demonstrated invasive carcinoma at surgical excision. Conclusion RS without atypia had a low upgrade rate. Keywords: Mammography, Breast © RSNA, 2021.
引用
- Yan P, DeMello L, Baird GL, et al. Malignancy Upgrade Rates of Radial Sclerosing Lesions at Breast Cancer Screening. Radiol Imaging Cancer. 2021. PMID: 34766844. doi:10.1148/rycan.2021210036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。